Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 63744-25-2 | MDL No. : | MFCD09835036 |
Formula : | C7H6BrN3O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | NFZLMWYHNQPCDZ-UHFFFAOYSA-N |
M.W : | 228.05 | Pubchem ID : | 11790955 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.14 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 47.18 |
TPSA : | 39.42 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.26 cm/s |
Log Po/w (iLOGP) : | 2.12 |
Log Po/w (XLOGP3) : | 2.02 |
Log Po/w (WLOGP) : | 1.5 |
Log Po/w (MLOGP) : | 0.42 |
Log Po/w (SILICOS-IT) : | 1.09 |
Consensus Log Po/w : | 1.43 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.02 |
Solubility : | 0.22 mg/ml ; 0.000965 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.48 |
Solubility : | 0.764 mg/ml ; 0.00335 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.7 |
Solubility : | 0.454 mg/ml ; 0.00199 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.6 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 5900-13-0 ]
5-Bromo-3-methoxypyrazin-2-amine
Similarity: 0.75
[ 77112-66-4 ]
2-Amino-5-bromo-3-ethoxypyrazine
Similarity: 0.73
[ 864076-05-1 ]
Methyl 4-bromo-1-methyl-1H-imidazole-2-carboxylate
Similarity: 0.71
[ 117718-84-0 ]
6-Bromoimidazo[1,2-a]pyrazin-8-amine
Similarity: 0.70
[ 5900-13-0 ]
5-Bromo-3-methoxypyrazin-2-amine
Similarity: 0.75
[ 77112-66-4 ]
2-Amino-5-bromo-3-ethoxypyrazine
Similarity: 0.73
[ 89282-38-2 ]
5-Bromo-3-methoxypyrazin-2(1H)-one
Similarity: 0.62
[ 187973-44-0 ]
2-Amino-3-benzyloxy-5-bromopyrazine
Similarity: 0.62
[ 117718-84-0 ]
6-Bromoimidazo[1,2-a]pyrazin-8-amine
Similarity: 0.70
[ 1208083-37-7 ]
6-Bromo-8-chloroimidazo[1,2-a]pyrazine
Similarity: 0.63
[ 1159811-97-8 ]
6-Bromo-2-methylimidazo[1,2-a]pyrazine
Similarity: 0.63
[ 1000018-56-3 ]
6-Bromoimidazo[1,2-a]pyrazine-2-carboxylic acid
Similarity: 0.62